Search for Clinical Trials
A Phase 2 Multi-Center Study Evaluating the Safety and Efficacy of CD30-Directed Genetically Modified Autologous T Cells (CD30.CAR-T) in Adult and…
The purpose of this study is to find out the highest safe dose of allogeneic CD30.CAR-EBVST cells given following chemotherapy and used to treat…
This study is for patients who have lymphoma or leukemia that has come back or has not gone away after treatment.
Currently, there are over 15.5 million individuals who either have cancer or have had a history of cancer, and this population continues to…
The purpose of this study is to evaluate the safety and tolerability of INCB050465 when combined with rituximab, bendamustine and rituximab, or…
This randomized, placebo-controlled phase 3 study is planned to enroll approximately 235 treatment-naïve subjects with high-risk Diffuse Large B-Cell…
NCI MATCH: Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple…
This research study combines antibodies and T cells to fight a type of blood cancer called T-cell leukemia or lymphoma (lymph gland cancer).
In this study lymphodepletion chemotherapy will be administered in patients who are not post autologous transplant in the hope that it will result in…
The purpose of this study is to determine the safety and efficacy of KTE-C19 in relapsed/refractory B-precursor acute lymphoblastic leukemia (ALL) in…
